Literature DB >> 7875683

Expression of SPARC in normal and fibrotic livers.

E Frizell1, S L Liu, A Abraham, I Ozaki, M Eghbali, E H Sage, M A Zern.   

Abstract

SPARC (secreted protein, acidic and rich in cysteine)--also known as osteonectin, BM-40, and 43K glycoprotein--is secreted by endothelial cells and fibroblasts in response to culture shock. SPARC has been found in association with tissues undergoing cell proliferation, migration, and extracellular matrix remodeling. We demonstrate that normal livers from humans, rats, and mice express substantial levels of SPARC messenger RNA (mRNA). Moreover, when compared with control specimens, significantly increased levels of SPARC mRNA were found in fibrotic livers from two animal models of liver disease: murine schistosomiasis and carbon tetrachloride-induced fibrosis in rats. Fibrotic human livers also had markedly increased levels of SPARC mRNA in comparison with normal livers. We also detected an increased production of SPARC protein in the liver of animals treated with carbon tetrachloride. By immunocytochemical analysis, SPARC protein was apparent in freshly isolated Ito cells. Hybridization studies showed Ito cells to be the main source of SPARC mRNA. Extracts from a Kupffer-endothelial cell fraction exhibited traces of SPARC transcript, but expression of SPARC mRNA was absent in extracts from freshly isolated hepatocytes. These studies demonstrate the increased expression of SPARC--a protein that modulates cell shape and disrupts cell-matrix interactions--during the initial stages of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875683

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

1.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

2.  Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.

Authors:  S Blazejewski; B Le Bail; L Boussarie; J F Blanc; L Malaval; K Okubo; J Saric; P Bioulac-Sage; J Rosenbaum
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

3.  A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.

Authors:  Gerald U Denk; Shi-Ying Cai; Wen-Sheng Chen; Aiping Lin; Carol J Soroka; James L Boyer
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  A fragment of SPARC reflecting increased collagen affinity shows pathological relevance in lung cancer - implications of a new collagen chaperone function of SPARC.

Authors:  S N Kehlet; T Manon-Jensen; S Sun; S Brix; D J Leeming; M A Karsdal; N Willumsen
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

5.  Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells.

Authors:  Sara M Thomasy; Joshua A Wood; Philip H Kass; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

6.  Expression of SPARC (secreted protein, acidic and rich in cysteine) in healing intestinal anastomoses and short bowel syndrome in rats.

Authors:  P Puolakkainen; M Reed; P Vento; E H Sage; T Kiviluoto; E Kivilaakso
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 7.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

8.  SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery.

Authors:  Li-Fong Seet; Roseline Su; V A Barathi; Wing Sum Lee; Rebekah Poh; Yee Meng Heng; Ed Manser; Eranga N Vithana; Tin Aung; Matt Weaver; E Helene Sage; Tina T Wong
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

9.  Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.

Authors:  Jiu-Cun Wang; Syeling Lai; Xinjian Guo; Xuefeng Zhang; Benoit de Crombrugghe; Sonali Sonnylal; Frank C Arnett; Xiaodong Zhou
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

Review 10.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.